Gilead Sciences - 26 Year Stock Split History | GILD

Stock split history for Gilead Sciences since 1992. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Gilead Sciences Annual Stock Splits
Gilead Sciences Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $87.604B $26.107B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $125.010B 14.13
Biogen (BIIB) United States $64.432B 13.05
Celgene (CELG) United States $48.591B 9.43
Illumina (ILMN) United States $48.348B 56.32
Vertex Pharmaceuticals (VRTX) United States $44.270B 77.33
Regeneron Pharmaceuticals (REGN) United States $40.656B 20.60
Alexion Pharmaceuticals (ALXN) United States $25.618B 17.53
BioMarin Pharmaceutical (BMRN) United States $16.442B 0.00
Incyte (INCY) United States $13.960B 385.88
Seattle Genetics (SGEN) United States $9.759B 0.00
Exact Sciences (EXAS) United States $8.544B 0.00
Sarepta Therapeutics (SRPT) United States $8.353B 0.00
BeiGene (BGNE) Cayman Islands $8.129B 0.00
QIAGEN (QGEN) Netherlands $7.997B 25.58
Alnylam Pharmaceuticals (ALNY) United States $7.758B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.571B 48.41
Exelixis (EXEL) United States $6.273B 17.78
Bio-Techne Corp (TECH) United States $5.949B 40.19
Bluebird Bio (BLUE) United States $5.733B 0.00
Alkermes (ALKS) Ireland $5.356B 3447.00
Amarin (AMRN) Ireland $5.351B 0.00
Galapagos (GLPG) Belgium $5.260B 0.00
Guardant Health (GH) United States $3.751B 0.00
Immunomedics (IMMU) United States $3.590B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.546B 0.00
Emergent Biosolutions (EBS) United States $3.378B 28.46
Array BioPharma (ARRY) United States $3.292B 0.00
Horizon Pharma Public (HZNP) Ireland $3.279B 13.49
ARGENX SE-ADR (ARGX) Netherlands $3.217B 0.00
Allogene Therapeutics (ALLO) United States $3.157B 0.00
Ligand Pharmaceuticals (LGND) United States $3.115B 23.83
Intercept Pharmaceuticals (ICPT) United States $3.102B 0.00
Akcea Therapeutics (AKCA) United States $2.861B 0.00
Repligen (RGEN) United States $2.713B 84.74
Ascendis Pharma (ASND) Denmark $2.613B 0.00
Allakos (ALLK) United States $2.590B 0.00
Genomic Health (GHDX) United States $2.586B 87.32
Blueprint Medicines (BPMC) United States $2.512B 0.00
China Biologic Products (CBPO) China $2.474B 17.61
ACADIA Pharmaceuticals (ACAD) United States $2.323B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.312B 0.00
Myriad Genetics (MYGN) United States $2.302B 22.81
Halozyme Therapeutics (HALO) United States $2.235B 49.87
Global Blood Therapeutics (GBT) United States $2.234B 0.00
Acceleron Pharma (XLRN) United States $2.212B 0.00
MyoKardia (MYOK) United States $2.194B 0.00
Arena Pharmaceuticals (ARNA) United States $2.024B 0.00
Amicus Therapeutics (FOLD) United States $1.999B 0.00
Denali Therapeutics (DNLI) United States $1.941B 0.00
Atara Biotherapeutics (ATRA) United States $1.934B 0.00
AnaptysBio (ANAB) United States $1.918B 0.00
REGENXBIO (RGNX) United States $1.915B 25.69
CRISPR Therapeutics AG (CRSP) Switzerland $1.853B 0.00
Innoviva (INVA) United States $1.766B 9.99
Reata Pharmaceuticals (RETA) United States $1.763B 0.00
Spark Therapeutics (ONCE) United States $1.540B 0.00
Medicines (MDCO) United States $1.529B 0.00
Cambrex (CBM) United States $1.484B 11.08
Rubius Therapeutics (RUBY) United States $1.483B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.476B 0.00
WAVE Life Sciences (WVE) Singapore $1.425B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.425B 113.17
Editas Medicine (EDIT) United States $1.415B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
Aimmune Therapeutics (AIMT) United States $1.364B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.332B 0.00
Mirati Therapeutics (MRTX) United States $1.309B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.308B 0.00
NeoGenomics (NEO) United States $1.290B 106.69
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
G1 THERAPEUTICS (GTHX) United States $1.233B 0.00
Lion Biotechnologies (IOVA) United States $1.222B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.206B 0.00
Insmed (INSM) United States $1.200B 0.00
Sangamo Therapeutics (SGMO) United States $1.199B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.169B 0.00
Clovis Oncology (CLVS) United States $1.132B 0.00
UniQure (QURE) Netherlands $1.071B 0.00
Fate Therapeutics (FATE) United States $1.056B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.022B 0.00
Apellis Pharmaceuticals (APLS) United States $1.009B 0.00
Retrophin (RTRX) United States $1.003B 0.00
Audentes Therapeutics (BOLD) United States $1.002B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.932B 0.00
Momenta Pharmaceuticals (MNTA) United States $0.909B 0.00
Puma Biotechnology (PBYI) United States $0.897B 0.00
Novavax (NVAX) United States $0.854B 0.00
Intra-Cellular Therapies (ITCI) United States $0.847B 0.00
Solid Biosciences (SLDB) United States $0.840B 0.00
Cellectis (CLLS) France $0.835B 0.00
DBV Technologies (DBVT) France $0.821B 0.00
Athenex (ATNX) United States $0.817B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.806B 0.00
Revance Therapeutics (RVNC) United States $0.804B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.781B 0.00
Acorda Therapeutics (ACOR) United States $0.769B 9.73
Vericel (VCEL) United States $0.761B 0.00
AC Immune SA (ACIU) Switzerland $0.761B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.752B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.751B 0.00
Heska (HSKA) United States $0.740B 60.60
Aptinyx (APTX) United States $0.732B 0.00
Gritstone Oncology (GRTS) United States $0.731B 0.00
Intellia Therapeutics (NTLA) United States $0.716B 0.00
Principia Biopharma (PRNB) United States $0.701B 0.00
InflaRx (IFRX) Germany $0.688B 0.00
Dynavax Technologies (DVAX) United States $0.678B 0.00
Scholar Rock Holding (SRRK) United States $0.678B 0.00
Viking Therapeutics (VKTX) United States $0.677B 0.00
Coherus BioSciences (CHRS) United States $0.672B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.665B 0.00
CytomX Therapeutics (CTMX) United States $0.654B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.648B 0.00
ANI Pharmaceuticals (ANIP) United States $0.646B 12.36
UROGEN PHARMA (URGN) Israel $0.626B 0.00
UNITY Biotechnology (UBX) $0.621B 0.00
Cara Therapeutics (CARA) United States $0.617B 0.00
TWIST BIOSCIENC (TWST) United States $0.612B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.609B 0.00
AVROBIO (AVRO) United States $0.589B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.548B 0.00
Arvinas (ARVN) United States $0.544B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.543B 0.00
Arcus Biosciences (RCUS) United States $0.540B 0.00
ObsEva SA (OBSV) Switzerland $0.534B 0.00
Kura Oncology (KURA) United States $0.533B 0.00
Eidos Therapeutics (EIDX) United States $0.521B 0.00
RA PHARMCTL INC (RARX) United States $0.515B 0.00
Kezar Life Sciences (KZR) United States $0.513B 0.00
Epizyme (EPZM) United States $0.512B 0.00
Inovio Pharmaceuticals (INO) United States $0.495B 0.00
Osiris Therapeutics (OSIR) United States $0.486B 0.00
BeyondSpring (BYSI) United States $0.478B 0.00
Prothena (PRTA) Ireland $0.464B 0.00
Zymeworks (ZYME) Canada $0.462B 0.00
Senesco Technologies (ELOX) United States $0.459B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.453B 0.00
Anika Therapeutics (ANIK) United States $0.445B 18.42
Replimune (REPL) United States $0.440B 0.00
PDL BioPharma (PDLI) United States $0.436B 7.12
Cytokineticsorporated (CYTK) United States $0.436B 0.00
Five Prime Therapeutics (FPRX) United States $0.427B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.423B 0.00
Kindred Biosciences (KIN) United States $0.420B 0.00
Sinovac Biotech (SVA) China $0.405B 0.00
Zealand Pharma (ZEAL) Denmark $0.392B 4.32
Mesoblast (MESO) Australia $0.388B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.385B 0.00
Abeona Therapeutics (ABEO) United States $0.382B 0.00
Cellular Biomedicine (CBMG) United States $0.373B 0.00
MediciNova (MNOV) United States $0.369B 0.00
ResTORbio (TORC) United States $0.354B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.351B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.345B 0.00
Liquidia Technologies (LQDA) United States $0.343B 0.00
Stemline Therapeutics (STML) United States $0.338B 0.00
Krystal Biotech (KRYS) United States $0.336B 0.00
MeiraGTx Holdings (MGTX) United States $0.331B 0.00
Sorrento Therapeutics (SRNE) United States $0.326B 53.40
Verastem (VSTM) United States $0.322B 0.00
Kodiak Sciences (KOD) United States $0.319B 0.00
Evelo Biosciences (EVLO) United States $0.317B 0.00
Agenus (AGEN) United States $0.314B 0.00
LogicBio Therapeutics (LOGC) United States $0.310B 0.00
Albireo Pharma (ALBO) United States $0.306B 0.00
Athersys (ATHX) United States $0.295B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.285B 0.00
Seres Therapeutics (MCRB) United States $0.283B 0.00
MannKind (MNKD) United States $0.278B 0.00
Syros Pharmaceuticals (SYRS) United States $0.277B 0.00
Magenta Therapeutics (MGTA) United States $0.276B 0.00
Merus (MRUS) Netherlands $0.274B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.271B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.264B 0.00
Geron (GERN) United States $0.261B 0.00
Kadmon Holdings (KDMN) United States $0.257B 0.00
TOCAGEN INC (TOCA) United States $0.256B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.254B 0.00
BioDelivery Sciences (BDSI) United States $0.250B 0.00
Equillium (EQ) United States $0.250B 0.00
Arbutus Biopharma (ABUS) Canada $0.246B 0.00
Intec Pharma (NTEC) Israel $0.246B 0.00
Celcuity (CELC) United States $0.234B 0.00
Adverum Biotechnologies (ADVM) United States $0.232B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
Celyad SA (CYAD) Belgium $0.227B 0.00
Aduro Biotech (ADRO) United States $0.222B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.221B 0.00
ADMA Biologics Inc (ADMA) United States $0.221B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.214B 0.00
Strongbridge Biopharma (SBBP) United States $0.213B 0.00
PSivida (EYPT) United States $0.208B 0.00
Urovant Sciences (UROV) United States $0.195B 0.00
Kamada (KMDA) Israel $0.195B 17.96
Aeglea BioTherapeutics (AGLE) United States $0.195B 0.00
Kala Pharmaceuticals (KALA) United States $0.193B 0.00
Synlogic (SYBX) United States $0.187B 0.00
Idera Pharmaceuticals (IDRA) United States $0.184B 0.00
Proteostasis Therapeutics (PTI) United States $0.181B 0.00
Allena Pharmaceuticals (ALNA) United States $0.180B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.178B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.177B 0.00
Unum Therapeutics (UMRX) United States $0.172B 0.00
CorMedix Inc (CRMD) United States $0.169B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.165B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.165B 0.00
BioTime (BTX) United States $0.163B 0.00
Protagonist Therapeutics (PTGX) United States $0.162B 0.00
Compugen (CGEN) Israel $0.162B 0.00
XBiotech (XBIT) United States $0.155B 0.00
Palatin Technologies (PTN) United States $0.154B 19.00
ChromaDex (CDXC) United States $0.154B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.154B 0.00
Axovant Sciences (AXON) United Kingdom $0.152B 0.00
Cohbar (CWBR) United States $0.151B 0.00
Constellation Pharmaceuticals (CNST) United States $0.148B 0.00
Enzo Biochem (ENZ) United States $0.139B 0.00
Cerecor (CERC) United States $0.137B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.136B 0.00
Menlo Therapeutics (MNLO) United States $0.132B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.126B 0.00
Mersana Therapeutics (MRSN) United States $0.124B 0.00
Selecta Biosciences (SELB) United States $0.122B 0.00
XOMA (XOMA) United States $0.122B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
Pfenex (PFNX) United States $0.120B 0.00
Organovo Holdings (ONVO) United States $0.119B 0.00
Eleven Biotherapeutics (SESN) United States $0.118B 0.00
Spero Therapeutics (SPRO) United States $0.118B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.117B 0.00
NantKwest (NK) United States $0.116B 0.00
Applied Genetic Technologies (AGTC) United States $0.111B 0.00
Pluristem Therapeutics (PSTI) Israel $0.110B 0.00
Cocrystal Pharma (COCP) United States $0.105B 117.33
Sienna Biopharmaceuticals (SNNA) United States $0.104B 0.00
ETON PHARMACEUT (ETON) United States $0.104B 0.00
Axsome Therapeutics (AXSM) United States $0.103B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.103B 0.00
VBI Vaccines (VBIV) United States $0.100B 0.00
Cue Biopharma (CUE) United States $0.097B 0.00
Motif Bio Plc (MTFB) United States $0.097B 0.00
Anavex Life Sciences (AVXL) United States $0.096B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.096B 0.00
Signal Genetics (MGEN) United States $0.096B 0.00
PHASEBIO PHARMA (PHAS) United States $0.095B 0.00
Neothetics (EVFM) United States $0.092B 0.00
Chiasma (CHMA) United States $0.091B 0.00
Cel-Sci (CVM) United States $0.091B 0.00
ScPharmaceuticals (SCPH) United States $0.087B 0.00
Mustang Bio (MBIO) United States $0.087B 0.00
Provention Bio (PRVB) United States $0.086B 0.00
Cidara Therapeutics (CDTX) United States $0.083B 0.00
Aptose Biosciences (APTO) Canada $0.083B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.080B 0.00
OVID THERAPEUTC (OVID) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Monster Digital (INNT) United States $0.075B 0.00
VolitionRX (VNRX) Singapore $0.073B 0.00
ITUS (ANIX) United States $0.073B 0.00
Checkpoint Therapeutics (CKPT) United States $0.073B 0.00
BioXcel Therapeutics (BTAI) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.069B 0.00
Bellerophon Therapeutics (BLPH) United States $0.067B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.064B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Sophiris Bio (SPHS) United States $0.062B 0.00
Ophthotech (OPHT) United States $0.061B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Evogene (EVGN) Israel $0.060B 0.00
Fortress Biotech (FBIO) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
Alcobra (ARCT) United States $0.055B 0.00
AEterna Zentaris (AEZS) United States $0.054B 10.31
Versartis (ARAV) United States $0.054B 4.73
VistaGen Therapeutics (VTGN) United States $0.053B 0.00
Trevena (TRVN) United States $0.052B 0.00
Arsanis (ASNS) United States $0.051B 0.00
Asterias Biotherapeutics (AST) United States $0.050B 0.00
OncoSec Medical (ONCS) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.047B 0.00
Leap Therapeutics (LPTX) United States $0.047B 0.00
Aptevo Therapeutics (APVO) United States $0.045B 0.00
Celldex Therapeutics (CLDX) United States $0.045B 0.00
Zosano Pharma (ZSAN) United States $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Oncobiologics (OTLK) United States $0.042B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.040B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Galena Biopharma (SLS) United States $0.038B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.037B 5.94
Celsion (CLSN) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
TRACON Pharmaceuticals (TCON) United States $0.034B 0.00
AquaBounty Technologies (AQB) United States $0.032B 0.00
Oragenics (OGEN) United States $0.031B 0.00
GTx (GTXI) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
AZURRX BIOPHARM (AZRX) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
DiaMedica Therapeutics (DMAC) United States $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Histogenics (HSGX) United States $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
BioPharmX (BPMX) United States $0.026B 0.00
IMMURON LTD (IMRN) Australia $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.021B 0.00
Curis (CRIS) United States $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
GENPREX INC (GNPX) United States $0.018B 0.00
CytRx (CYTR) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Cellect Biotechnology (APOP) Israel $0.017B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 8.70
ATyr Pharma (LIFE) United States $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.015B 0.00
Edge Therapeutics (EDGE) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Adial Pharmaceuticals (ADIL) United States $0.013B 0.00
Prana Biotechnology (PRAN) Australia $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
RestorGenex (DFFN) United States $0.011B 0.00
Vital Therapies (VTL) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Cerulean Pharma (DARE) United States $0.009B 0.00
Neuralstem (CUR) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
AmpliPhi Biosciences (APHB) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00